Viracta Therapeutics, Inc. (VIRX)

Viracta Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	19	22	56	136	36	38
Market Cap Growth	-34.41%	-60.52%	-59.05%	278.25%	-4.22%	141.66%
Enterprise Value	-1	-6	-10	38	-5	9
PE Ratio	-	-0.43	-1.13	-1.19	-1.89	-1.61
PS Ratio	-	-	-	-	-	18.13
PB Ratio	1.74	1.20	0.91	1.44	-0.78	1.37
P/FCF Ratio	-1.10	-0.55	-1.57	-7.13	-2.24	-1.69
P/OCF Ratio	-1.10	-0.55	-1.57	-7.22	-2.24	-1.69
EV/Sales Ratio	-	-	-	-	-	4.46
EV/EBITDA Ratio	-0.44	0.13	0.21	-0.33	0.26	-0.41
EV/EBIT Ratio	-0.44	0.13	0.21	-0.33	0.26	-0.41
EV/FCF Ratio	-0.53	0.15	0.29	-2.00	0.30	-0.42
Debt / Equity Ratio	1.70	1.40	0.41	0.06	-0.13	0.23
Debt / EBITDA Ratio	-0.43	-0.55	-0.52	-0.05	-0.33	-0.28
Debt / FCF Ratio	-0.52	-0.64	-0.71	-0.29	-0.38	-0.28
Quick Ratio	1.31	1.40	9.09	11.40	7.49	3.68
Current Ratio	1.35	1.43	9.36	11.59	7.51	3.86
Asset Turnover	0	0	0	0	0	0.07
Interest Coverage	-12.04	-12.78	-84.26	-232.73	-87.04	-44.39
Return on Equity (ROE)	-191.60%	-145.60%	-67.50%	-104.30%	-462.20%	-105.30%
Return on Assets (ROA)	-79.50%	-71.50%	-53.80%	-93.70%	-57.10%	-73.10%
Return on Capital (ROIC)	-174.91%	-115.54%	-58.65%	-114.45%	47.01%	-68.85%
Earnings Yield	-249.38%	-231.91%	-88.22%	-84.27%	-52.82%	-62.06%
FCF Yield	-189.88%	-181.82%	-63.66%	-14.03%	-44.74%	-59.01%
Buyback Yield / Dilution	-2.25%	-2.21%	-18.58%	-9714.39%	86.95%	-144.84%
Total Shareholder Return	-2.25%	-2.21%	-18.58%	-9714.39%	86.95%	-144.84%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).